Avenir Corporation’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-28,460
| Closed | -$137K | – | 67 |
|
|
2023
Q4 | $137K | Hold |
28,460
| – | – | 0.01% | 61 |
|
|
2023
Q3 | $206K | Hold |
28,460
| – | – | 0.02% | 58 |
|
|
2023
Q2 | $211K | Sell |
28,460
-150
| -0.5% | -$1.18K | 0.02% | 58 |
|
|
2023
Q1 | $198K | Sell |
28,610
-21,004
| -42% | -$193K | 0.02% | 61 |
|
|
2022
Q4 | $510K | Hold |
49,614
| – | – | 0.05% | 44 |
|
|
2022
Q3 | $903K | Hold |
49,614
| – | – | 0.1% | 38 |
|
|
2022
Q2 | $2.55M | Hold |
49,614
| – | – | 0.24% | 30 |
|
|
2022
Q1 | $3.65M | Hold |
49,614
| – | – | 0.29% | 27 |
|
|
2021
Q4 | $7.1M | Hold |
49,614
| – | – | 0.55% | 25 |
|
|
2021
Q3 | $10.3M | Hold |
49,614
| – | – | 0.86% | 23 |
|
|
2021
Q2 | $10.5M | Hold |
49,614
| – | – | 0.84% | 23 |
|
|
2021
Q1 | $9M | Sell |
49,614
-9,340
| -16% | -$1.86M | 0.78% | 24 |
|
|
2020
Q4 | $6.57M | Hold |
58,954
| – | – | 0.63% | 23 |
|
|
2020
Q3 | $6.39M | Sell |
58,954
-20,165
| -25% | -$2.46M | 0.67% | 25 |
|
|
2020
Q2 | $6.59M | Sell |
79,119
-27,346
| -26% | -$1.05M | 0.75% | 23 |
|
|
2020
Q1 | $1.45M | Buy |
106,465
+1,000
| +0.9% | +$8.46K | 0.2% | 37 |
|
|
2019
Q4 | $420K | Buy |
105,465
+49,865
| +90% | +$216K | 0.04% | 61 |
|
|
2019
Q3 | $279K | Buy |
55,600
+44,300
| +392% | +$242K | 0.03% | 62 |
|
|
2019
Q2 | $66K | Buy |
11,300
+365
| +3% | +$2.87K | 0.01% | 68 |
|
|
2019
Q1 | $120K | Buy |
+10,935
| New | +$345K | 0.01% | 65 |
|
|
2016
Q4 | – | Sell |
-900
| Closed | -$37K | – | 70 |
|
|
2016
Q3 | $37K | Hold |
900
| – | – | ﹤0.01% | 69 |
|
|
2016
Q2 | $131K | Hold |
900
| – | – | 0.01% | 64 |
|
|
2016
Q1 | $93K | Hold |
900
| – | – | 0.01% | 64 |
|
|
2015
Q4 | $151K | Hold |
900
| – | – | 0.01% | 69 |
|
|
2015
Q3 | $127K | Hold |
900
| – | – | 0.01% | 57 |
|
|
2015
Q2 | $201K | Hold |
900
| – | – | 0.01% | 57 |
|
|
2015
Q1 | $149K | Hold |
900
| – | – | 0.01% | 58 |
|
|
2014
Q4 | $107K | Hold |
900
| – | – | 0.01% | 59 |
|
|
2014
Q3 | $75K | Buy |
900
+100
| +13% | +$9.04K | 0.01% | 65 |
|
|
2014
Q2 | $74K | Buy |
+800
| New | +$70.3K | 0.01% | 69 |
|
Other funds holding NVAX
SCM
Avenir Corporation's NVAX Position: Q1 2024 in Review
Avenir Corporation sold out of Novavax (NVAX) in Q1 2024, closing a stake of 28,460 shares — an estimated $137K sold.
Avenir Corporation first reported a position in NVAX in Q2 2014 and held it in 30 quarters. The position peaked at $10.5M in Q2 2021. 202 funds tracked by Wall St. Rank hold NVAX as of Q1 2024.
- Avenir Corporation reported no remaining Novavax position as of Q1 2024 after selling out during the quarter.
- Avenir Corporation sold 28,460 Novavax shares in Q1 2024, an estimated $137K.
- Avenir Corporation first reported a position in Novavax in Q2 2014 and held it in 30 quarters.
- Avenir Corporation's Novavax position peaked at $10.5M in Q2 2021.
- 202 funds tracked by Wall St. Rank held Novavax as of Q1 2024.
Based on Avenir Corporation's 13F filing for Q1 2024, filed 16 May 2024.